Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Research, science & health

Enjoying now or saving for later: are we predisposed to choose?

Published on: 23/02/2023 Reading time: 1 min
Une horloge avec un fond de deux couleurs
Retour à la recherche

Léonie KOBAN and Hilke PLASMANN, researchers in the team "CIA: cognitive control - interoception - attention", have identified a novel brain marker using functional imaging that predicts our preference for immediate rewards over larger later rewards. This work is published in the Journal of Neuroscience.

Delay discounting (DD)

Delay discounting (DD) is a cognitive process that describes to what degree individuals are willing to wait for larger monetary pay-off that they receive in the future or whether they prefer to receive a smaller one now (e.g., 1 EUR now vs. 2 EUR in a week). The more people discount time, the more they to prefer to receive an immediate reward rather than wait for a larger reward that is only available in the future. We are all regularly faced with this type of choice: for instance, when we decide to buy some new shoes today or save to the money for a nice vacation in the summer, whether we eat a snack in the afternoon or save our appetite for dinner, and whether we go out with friends in the evening or go to bed early to be rested the next day.

DD is highly variable from one person to the next but remains stable over time for the same person. Previous studies have associated DD as a risk factor in eating disorders (obesity or anorexia), smoking, alcohol use disorder, or drug addiction.

The aim of the study conducted by the Institute's researchers was to identify a replicable machine-learning based brain marker predictive of DD and to validate it in an independent population.

 

Assessing trends in choices

To this end, 255 healthy volunteers were asked to make choices between smaller immediate and larger later rewards during a functional MRI scan. The researchers also measured the body weight and height, the percentage of fat mass, blood insulin, and glucose levels of the study participants.

 

Significant results: the brain signature of DD

The researchers from the ICM and their colleagues used a machine learning algorithm to detect a pattern of functional brain activity that could predict individual differences in delay discounting. Machine learning is a form of artificial intelligence that allows a mathematical and statistical model to predict new data based on previously analyzed data.

The results of the study showed that it was possible to predict a person’s degree of delay discounting based on their functional brain activity across different brain regions. Furthermore, the researchers found that the marker was related to individual differences in blood insulin and glucose—two metabolic markers—and that it  differed between overweight and normal weight individuals.

Future studies can test this marker in disorders characterized by impaired decision making, such as eating disorders, addictions, or neurodegenerative diseases like Alzheimer's or Parkinson's.

Sources

Koban L, Lee S, Schelski DS, Simon MC, Lerman C, Weber B, Kable JW, Plassmann H. An fMRI-based brain marker of individual differences in delay discounting. J Neurosci. 2023 Jan 18:JN-RM-1343-22. doi: 10.1523/JNEUROSCI.1343-22.2022. Epub ahead of print. PMID: 36657973.

Our news on the subject

Sclérose en plaques : identification d’une nouvelle molécule favorisant la remyélinisation
Multiple Sclerosis: Identification of a Molecule that Promotes Repair of the Nervous System
A molecule previously studied in the context of sleep disorders and attention deficit hyperactivity disorder (ADHD) is now, for the first time, revealing its potential in experimental models of multiple sclerosis (MS): it protects neurons and...
01.27.2026 Research, science & health
VignetteActu WBHF 2026
World Brain Health Forum 2026
More than one in three people will experience a brain disorder at some point in their lives. This reality, identified by the World Health Organization as a major public health priority, calls for unprecedented international mobilization. It is...
01.12.2026 Events
Une nouvelle approche pour évaluer les patients en état de conscience altérée
A New Approach to Assessing Patients with Disorders of Consciousness
In intensive care units, some patients who appear unconscious occupy a gray zone in their relationship to the world. To better diagnose them and predict their recovery potential, Dragana Manasova, Jacobo Sitt, and their colleagues have developed an...
01.08.2026 Research, science & health
Ne plus penser à rien : vers une signature cérébrale du blanc mental
Not Thinking About Anything: Toward a Brain Signature of Mind Blanking
What if the flow of our thoughts occasionally just stopped? Esteban Munoz-Musat, Lionel Naccache, Thomas Andrillon, and their colleagues at Paris Brain Institute and Monash University in Melbourne show that the sensation of “thinking about nothing”...
12.26.2025 Research, science & health
Deux nouvelles certifications pour les plateformes de l’Institut du Cerveau
Two new certifications for Paris Brain Institute’s core facilities
Paris Brain Institute’s core facilities were recently awarded two new certifications: ISO 9001 certification for ICM.Quant and ISO 20387 certification for its DNA & Cell Bank.
11.14.2025 Institutional
La dépression résistante possède une signature moléculaire spécifique
Treatment-resistant depression identified as a distinct molecular subtype
An international study published in Brain, Behavior, and Immunity shows that patients with treatment-resistant depression (TRD) have a unique biology, different from those who respond to standard therapies. More than 5,000 genes were found to behave...
11.03.2025 Research, science & health
See all our news